Medtronic PLC vs ProShares UltraPro S&P500 — how do they compare? Medtronic PLC trades at $90.25 (market cap $116.07B), while ProShares UltraPro S&P500 trades at $154.3. The key difference: Medtronic PLC pays a 3.18% dividend while ProShares UltraPro S&P500 pays none, and ProShares UltraPro S&P500 is trading nearer its 52-week high, Medtronic PLC nearer its low. Which is the better fit depends on your goals.
| MDT | UPRO | |
|---|---|---|
Market Cap | $116.07B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $105.35 | $155.10 |
52-Week Low | $73.75 | $89.29 |
Enterprise Value | $134.82B | — |
Dividend Yield | 3.18% | — |
Trailing returns across standard periods
Latest headlines on both assets
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →UPRO is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the S&P 500 Index. It is a tactical, high-conviction instrument designed for short-term traders to amplify bullish market moves, utilizing a daily reset mechanism that creates significant compounding effects and volatility risks over time.
Read more on UPRO →